Related Experiment Videos
Thyroid cancers. II. Medullary, anaplastic, lymphoma, sarcoma, squamous cell
J R Austin1, A K el-Naggar, H Goepfert
1Department of Head and Neck Surgery, University of Texas M. D. Anderson Cancer Center, Houston, USA.
Otolaryngologic Clinics of North America
|August 1, 1996
Summary
Early detection and tailored treatments offer cures for medullary thyroid carcinoma (MTC) and improve outcomes for other thyroid cancers. Genetic screening aids familial MTC diagnosis, while new therapies enhance survival for advanced and rare thyroid malignancies.
Area of Science:
- Oncology
- Genetics
- Surgical Oncology
Background:
- Medullary thyroid carcinoma (MTC), both sporadic and familial, is curable with early detection and appropriate surgery.
- Advancements in genetic screening for the RET protooncogene offer improved early diagnosis and treatment for familial MTC.
- Metastatic MTC and other rare thyroid cancers like anaplastic thyroid cancer, lymphoma, sarcomas, and squamous cell carcinoma (SCC) present significant treatment challenges.
Purpose of the Study:
- To review current and emerging treatment strategies for various types of thyroid cancer.
- To highlight the importance of early diagnosis and personalized treatment approaches.
- To discuss the role of surgery, chemotherapy, radiotherapy, and genetic screening in managing thyroid malignancies.
Main Methods:
- Review of current literature on thyroid cancer treatment modalities.
- Analysis of the impact of genetic screening (RET protooncogene) on familial MTC management.
- Evaluation of chemotherapy protocols, radiotherapy techniques, and surgical interventions for different thyroid cancer types.
Main Results:
- Early detection and surgery are crucial for curable MTC.
- Genetic screening for RET protooncogene facilitates earlier diagnosis of familial MTC.
- New chemotherapy regimens show promise in regressing metastatic MTC.
- Combined chemoradiotherapy offers a good prognosis for early-diagnosed thyroid lymphoma.
- Aggressive surgery and radiotherapy are key for thyroid sarcomas and SCC.
Conclusions:
- Optimal surgical treatment and early detection are paramount for curable thyroid cancers like MTC.
- Genetic screening and novel therapeutic strategies, including chemotherapy and radiotherapy, are improving survival rates for advanced and rare thyroid malignancies.
- Multimodal treatment approaches combining surgery, chemotherapy, and radiotherapy are essential for managing aggressive thyroid cancers.